Literature DB >> 7283563

Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology.

D L Simpson, B H Rumack.   

Abstract

Methylenedioxyamphetamine is a commonly used "street drug", with a reputation of providing a "good trip". The drug is structurally similar to both mescaline and amphetamine. The following symptoms were found in a patient: sympathomimetic effects, coma, seizures, hyperreflexia, and hyperthermia. The patient's condition was initially stabilized and then deteriorated with uncontrollable hyperthermia, hematologic abnormalities, and coma that culminated in death. Since the hyperthermia is based on both central and peripheral mechanisms, phentolamine (Regitine) mesylate may be the preferred drug to be used in the treatment of future cases. The concept that this drug is primarily a hallucinogen with mild toxicity is erroneous.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283563     DOI: 10.1001/archinte.141.11.1507

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 2.  Methamphetamine and the expanding complications of amphetamines.

Authors:  T E Albertson; R W Derlet; B E Van Hoozen
Journal:  West J Med       Date:  1999-04

Review 3.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

4.  Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.

Authors:  M A Nader; S M Hoffmann; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  'Designer drugs'. A problem in clinical toxicology.

Authors:  J F Buchanan; C R Brown
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

Review 6.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

7.  Occurrence of rhabdomyolysis, serotonin syndrome, and acute respiratory distress syndrome in a child secondary to ecstasy intoxication.

Authors:  Osman Yeşilbaş; Selçuk Uzuner; Çiğdem Korkmaz; Lala Nurmammadova; Ayşegül Doğan Demir
Journal:  Turk Pediatri Ars       Date:  2019-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.